

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of complement activation (GO:0045916) | 7.35946820 |
| 2 | response to xenobiotic stimulus (GO:0009410) | 7.28449854 |
| 3 | pattern specification involved in kidney development (GO:0061004) | 6.86539076 |
| 4 | negative regulation of protein activation cascade (GO:2000258) | 6.56463859 |
| 5 | cellular response to nitric oxide (GO:0071732) | 6.28595154 |
| 6 | negative regulation of humoral immune response (GO:0002921) | 6.14595502 |
| 7 | positive regulation of endothelial cell differentiation (GO:0045603) | 6.01081677 |
| 8 | morphogenesis of an endothelium (GO:0003159) | 5.49538753 |
| 9 | endothelial tube morphogenesis (GO:0061154) | 5.49538753 |
| 10 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 5.42863888 |
| 11 | regulation of endothelial cell differentiation (GO:0045601) | 5.39614032 |
| 12 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 5.23979126 |
| 13 | lung lobe morphogenesis (GO:0060463) | 5.15920072 |
| 14 | cellular response to reactive nitrogen species (GO:1902170) | 4.83176755 |
| 15 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 4.69603852 |
| 16 | response to nitric oxide (GO:0071731) | 4.66459711 |
| 17 | sodium-independent organic anion transport (GO:0043252) | 4.65872820 |
| 18 | regulation of phospholipid biosynthetic process (GO:0071071) | 4.59813167 |
| 19 | phosphate ion transmembrane transport (GO:0035435) | 4.59588560 |
| 20 | epithelial tube branching involved in lung morphogenesis (GO:0060441) | 4.48656548 |
| 21 | regulation of vasculogenesis (GO:2001212) | 4.27838411 |
| 22 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 4.22950390 |
| 23 | regulation of complement activation (GO:0030449) | 4.18254959 |
| 24 | trivalent inorganic anion homeostasis (GO:0072506) | 4.15223973 |
| 25 | phosphate ion homeostasis (GO:0055062) | 4.15223973 |
| 26 | endocrine hormone secretion (GO:0060986) | 4.10513560 |
| 27 | peptide catabolic process (GO:0043171) | 4.04202895 |
| 28 | mesodermal cell differentiation (GO:0048333) | 3.98520649 |
| 29 | respiratory tube development (GO:0030323) | 3.93421493 |
| 30 | cellular anion homeostasis (GO:0030002) | 3.91533086 |
| 31 | sodium ion homeostasis (GO:0055078) | 3.87013628 |
| 32 | regulation of protein activation cascade (GO:2000257) | 3.85122122 |
| 33 | lung vasculature development (GO:0060426) | 3.84938063 |
| 34 | blood vessel maturation (GO:0001955) | 3.83801758 |
| 35 | regulation of interleukin-13 production (GO:0032656) | 3.81394172 |
| 36 | phosphate ion transport (GO:0006817) | 3.79039170 |
| 37 | establishment of apical/basal cell polarity (GO:0035089) | 3.75977576 |
| 38 | negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394) | 3.75417011 |
| 39 | endocardial cushion development (GO:0003197) | 3.72680460 |
| 40 | hyperosmotic salinity response (GO:0042538) | 3.70991966 |
| 41 | virion attachment to host cell (GO:0019062) | 3.65544102 |
| 42 | adhesion of symbiont to host cell (GO:0044650) | 3.65544102 |
| 43 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 3.57538275 |
| 44 | glomerular epithelial cell development (GO:0072310) | 3.56251683 |
| 45 | complement activation, classical pathway (GO:0006958) | 3.54915922 |
| 46 | protein localization to endosome (GO:0036010) | 3.54753590 |
| 47 | lung alveolus development (GO:0048286) | 3.53387535 |
| 48 | cellular hyperosmotic response (GO:0071474) | 3.53165599 |
| 49 | glomerular filtration (GO:0003094) | 3.51750504 |
| 50 | macrophage chemotaxis (GO:0048246) | 3.51235645 |
| 51 | hemidesmosome assembly (GO:0031581) | 3.47326328 |
| 52 | complement activation (GO:0006956) | 3.46935349 |
| 53 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.42851058 |
| 54 | negative regulation of interleukin-2 production (GO:0032703) | 3.41113263 |
| 55 | iron ion import (GO:0097286) | 3.41085943 |
| 56 | lymphangiogenesis (GO:0001946) | 3.40341633 |
| 57 | renal absorption (GO:0070293) | 3.39929329 |
| 58 | induction of positive chemotaxis (GO:0050930) | 3.38344821 |
| 59 | cell adhesion mediated by integrin (GO:0033627) | 3.32470779 |
| 60 | * respiratory gaseous exchange (GO:0007585) | 3.26874121 |
| 61 | regulation of glomerular filtration (GO:0003093) | 3.26101846 |
| 62 | negative regulation of response to reactive oxygen species (GO:1901032) | 3.25131509 |
| 63 | establishment or maintenance of monopolar cell polarity (GO:0061339) | 3.21496010 |
| 64 | establishment of monopolar cell polarity (GO:0061162) | 3.21496010 |
| 65 | lung secretory cell differentiation (GO:0061140) | 3.16636377 |
| 66 | glomerular visceral epithelial cell development (GO:0072015) | 3.16393055 |
| 67 | Leydig cell differentiation (GO:0033327) | 3.15052500 |
| 68 | sphingosine metabolic process (GO:0006670) | 3.13272919 |
| 69 | embryonic foregut morphogenesis (GO:0048617) | 3.10228148 |
| 70 | branch elongation of an epithelium (GO:0060602) | 3.10182749 |
| 71 | regulation of branching involved in prostate gland morphogenesis (GO:0060687) | 3.07631612 |
| 72 | adhesion of symbiont to host (GO:0044406) | 3.06669591 |
| 73 | positive regulation of vasculogenesis (GO:2001214) | 3.04976129 |
| 74 | response to vitamin A (GO:0033189) | 3.04667151 |
| 75 | negative regulation of alcohol biosynthetic process (GO:1902931) | 3.02057128 |
| 76 | hormone catabolic process (GO:0042447) | 2.96228025 |
| 77 | protein activation cascade (GO:0072376) | 2.95500527 |
| 78 | positive regulation of digestive system process (GO:0060456) | 2.95439035 |
| 79 | axis elongation (GO:0003401) | 2.95097544 |
| 80 | regulation of hippo signaling (GO:0035330) | 2.94844172 |
| 81 | extracellular matrix assembly (GO:0085029) | 2.94731716 |
| 82 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.94140477 |
| 83 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.93787557 |
| 84 | cellular response to antibiotic (GO:0071236) | 2.92937451 |
| 85 | cellular sodium ion homeostasis (GO:0006883) | 2.91993882 |
| 86 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.91382282 |
| 87 | polyol transport (GO:0015791) | 2.90736877 |
| 88 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.89417509 |
| 89 | phosphatidylglycerol acyl-chain remodeling (GO:0036148) | 2.87731806 |
| 90 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.87462422 |
| 91 | one-carbon compound transport (GO:0019755) | 2.86813186 |
| 92 | response to increased oxygen levels (GO:0036296) | 2.85559712 |
| 93 | response to hyperoxia (GO:0055093) | 2.85559712 |
| 94 | segment specification (GO:0007379) | 2.85085918 |
| 95 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.83808138 |
| 96 | icosanoid transport (GO:0071715) | 2.82377781 |
| 97 | fatty acid derivative transport (GO:1901571) | 2.82377781 |
| 98 | gas transport (GO:0015669) | 2.81260133 |
| 99 | negative regulation of fatty acid transport (GO:2000192) | 2.80923325 |
| 100 | membrane protein proteolysis (GO:0033619) | 2.79489396 |
| 101 | artery development (GO:0060840) | 2.78898688 |
| 102 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 2.78364368 |
| 103 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 2.78256243 |
| 104 | multicellular organismal water homeostasis (GO:0050891) | 2.74761598 |
| 105 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.74514145 |
| 106 | endothelial cell chemotaxis (GO:0035767) | 2.71715161 |
| 107 | diol metabolic process (GO:0034311) | 2.70012846 |
| 108 | norepinephrine metabolic process (GO:0042415) | 2.69481881 |
| 109 | regulation of interleukin-5 production (GO:0032674) | 2.69477864 |
| 110 | receptor catabolic process (GO:0032801) | 2.68195847 |
| 111 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class | 2.68016251 |
| 112 | branching involved in salivary gland morphogenesis (GO:0060445) | 2.67773540 |
| 113 | membrane raft organization (GO:0031579) | 2.67426561 |
| 114 | renal filtration (GO:0097205) | 2.65346345 |
| 115 | response to interleukin-6 (GO:0070741) | 2.65316595 |
| 116 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.64035350 |
| 117 | renal system process involved in regulation of blood volume (GO:0001977) | 2.63856948 |
| 118 | tight junction assembly (GO:0070830) | 2.63822409 |
| 119 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.62719143 |
| 120 | negative regulation of T cell proliferation (GO:0042130) | 2.62567655 |
| 121 | toxin metabolic process (GO:0009404) | 2.62285102 |
| 122 | protein autoprocessing (GO:0016540) | 2.60002899 |
| 123 | import into cell (GO:0098657) | 2.59808486 |
| 124 | endothelial cell differentiation (GO:0045446) | 2.59456781 |
| 125 | negative regulation of stress fiber assembly (GO:0051497) | 2.59381907 |
| 126 | negative regulation of epithelial to mesenchymal transition (GO:0010719) | 2.58783042 |
| 127 | polarized epithelial cell differentiation (GO:0030859) | 2.58546609 |
| 128 | blood vessel remodeling (GO:0001974) | 2.58411164 |
| 129 | positive regulation of p38MAPK cascade (GO:1900745) | 2.57669118 |
| 130 | complement activation, alternative pathway (GO:0006957) | 2.57347179 |
| 131 | establishment of endothelial barrier (GO:0061028) | 2.56476423 |
| 132 | atrioventricular valve morphogenesis (GO:0003181) | 2.55528390 |
| 133 | toxin transport (GO:1901998) | 2.54875289 |
| 134 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.54511785 |
| 135 | negative regulation of actin filament bundle assembly (GO:0032232) | 2.53523494 |
| 136 | glial cell proliferation (GO:0014009) | 2.53471801 |
| 137 | positive regulation of chemokine secretion (GO:0090197) | 2.52451340 |
| 138 | coronary vasculature morphogenesis (GO:0060977) | 2.51781729 |
| 139 | T cell mediated immunity (GO:0002456) | 2.50894866 |
| 140 | regulation of p38MAPK cascade (GO:1900744) | 2.50616875 |
| 141 | regulation of humoral immune response (GO:0002920) | 2.49362837 |
| 142 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.49004802 |
| 143 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.48792761 |
| 144 | response to thyroid hormone (GO:0097066) | 2.48629544 |
| 145 | neuron remodeling (GO:0016322) | 2.48263237 |
| 146 | apoptotic cell clearance (GO:0043277) | 2.47403145 |
| 147 | ethanol oxidation (GO:0006069) | 2.46707953 |
| 148 | regulation of macrophage chemotaxis (GO:0010758) | 2.44243459 |
| 149 | keratan sulfate catabolic process (GO:0042340) | 2.42618529 |
| 150 | positive regulation of phosphatase activity (GO:0010922) | 2.42359144 |
| 151 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 2.41569444 |
| 152 | negative regulation of blood vessel endothelial cell migration (GO:0043537) | 2.36857865 |
| 153 | fibroblast migration (GO:0010761) | 2.36224177 |
| 154 | cell volume homeostasis (GO:0006884) | 2.35900416 |
| 155 | positive regulation of phagocytosis (GO:0050766) | 2.32145310 |
| 156 | surfactant homeostasis (GO:0043129) | 18.9504650 |
| 157 | chemical homeostasis within a tissue (GO:0048875) | 15.1883942 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GATA1_22025678_ChIP-Seq_K562_Human | 4.61998657 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.71556346 |
| 3 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.45393580 |
| 4 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 3.26330090 |
| 5 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.76554223 |
| 6 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.76439509 |
| 7 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.68722477 |
| 8 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.67933646 |
| 9 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.63818539 |
| 10 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.61990016 |
| 11 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.57510330 |
| 12 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.54377296 |
| 13 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.41901788 |
| 14 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.41297633 |
| 15 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.32810174 |
| 16 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.29116608 |
| 17 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 2.27564021 |
| 18 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.26121454 |
| 19 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.10592010 |
| 20 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.06144946 |
| 21 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.96844878 |
| 22 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.94593686 |
| 23 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.93918880 |
| 24 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.90358229 |
| 25 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.80249903 |
| 26 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.80147675 |
| 27 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.78309451 |
| 28 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.64041993 |
| 29 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.64017502 |
| 30 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.62298288 |
| 31 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.62245250 |
| 32 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.61951310 |
| 33 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.60001033 |
| 34 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.59546209 |
| 35 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.58878721 |
| 36 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.58832631 |
| 37 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.57736271 |
| 38 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.54615775 |
| 39 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.54425903 |
| 40 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.54037354 |
| 41 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.52374612 |
| 42 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.51477639 |
| 43 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.51057320 |
| 44 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.47165653 |
| 45 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.47165653 |
| 46 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.46766602 |
| 47 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.46632682 |
| 48 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.44511885 |
| 49 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.42457836 |
| 50 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.42014553 |
| 51 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.41567871 |
| 52 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.41481673 |
| 53 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.39651200 |
| 54 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.39429276 |
| 55 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.38391398 |
| 56 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.38036076 |
| 57 | CJUN_26792858_Chip-Seq_BT549_Human | 1.35202281 |
| 58 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.34095744 |
| 59 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.33517867 |
| 60 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.31997140 |
| 61 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.31902119 |
| 62 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.30390862 |
| 63 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.30249542 |
| 64 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.29604757 |
| 65 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.27615877 |
| 66 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.26272918 |
| 67 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.25169209 |
| 68 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.24148054 |
| 69 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.24092403 |
| 70 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.24092403 |
| 71 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.23945271 |
| 72 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.22475915 |
| 73 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.22189827 |
| 74 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.21285525 |
| 75 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.20746144 |
| 76 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.19782994 |
| 77 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.19129832 |
| 78 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.18723461 |
| 79 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.18207254 |
| 80 | SPI1_23127762_ChIP-Seq_K562_Human | 1.17926293 |
| 81 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.17238152 |
| 82 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.16384298 |
| 83 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.14824201 |
| 84 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.13692302 |
| 85 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.11513390 |
| 86 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.11475635 |
| 87 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.11333866 |
| 88 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.10924637 |
| 89 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.10890477 |
| 90 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.10081846 |
| 91 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.10044781 |
| 92 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.09340226 |
| 93 | GATA1_19941826_ChIP-Seq_K562_Human | 1.09238446 |
| 94 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.08037804 |
| 95 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.08037804 |
| 96 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.07426955 |
| 97 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.07335224 |
| 98 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.06808074 |
| 99 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.06183521 |
| 100 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.05602704 |
| 101 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.05229839 |
| 102 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.05064705 |
| 103 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.04712605 |
| 104 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.04592183 |
| 105 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.03419018 |
| 106 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.03211495 |
| 107 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.02894545 |
| 108 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.02611567 |
| 109 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.01004369 |
| 110 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.99658432 |
| 111 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.99124990 |
| 112 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.99009362 |
| 113 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.98048861 |
| 114 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.97347957 |
| 115 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.97002271 |
| 116 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.94962953 |
| 117 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.94368496 |
| 118 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.93530189 |
| 119 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.93184902 |
| 120 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.92897377 |
| 121 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.92800224 |
| 122 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.92659798 |
| 123 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.92576413 |
| 124 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.92548211 |
| 125 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.92337801 |
| 126 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.91344314 |
| 127 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.91170223 |
| 128 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.91042202 |
| 129 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.90303181 |
| 130 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.89490871 |
| 131 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.89087518 |
| 132 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.88072914 |
| 133 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.87051739 |
| 134 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.85999774 |
| 135 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.84350180 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004782_abnormal_surfactant_physiolog | 9.97782200 |
| 2 | MP0001958_emphysema | 6.03306707 |
| 3 | MP0008995_early_reproductive_senescence | 4.94882319 |
| 4 | MP0008004_abnormal_stomach_pH | 4.26554373 |
| 5 | MP0005083_abnormal_biliary_tract | 4.12417782 |
| 6 | MP0010368_abnormal_lymphatic_system | 3.68090392 |
| 7 | MP0002138_abnormal_hepatobiliary_system | 3.10833147 |
| 8 | MP0003724_increased_susceptibility_to | 2.90506080 |
| 9 | MP0001542_abnormal_bone_strength | 2.88759691 |
| 10 | MP0002295_abnormal_pulmonary_circulatio | 2.64226539 |
| 11 | MP0005167_abnormal_blood-brain_barrier | 2.50008034 |
| 12 | MP0001879_abnormal_lymphatic_vessel | 2.43640168 |
| 13 | * MP0002133_abnormal_respiratory_system | 2.40991502 |
| 14 | * MP0005388_respiratory_system_phenotype | 2.40991502 |
| 15 | MP0003191_abnormal_cellular_cholesterol | 2.37518565 |
| 16 | MP0000537_abnormal_urethra_morphology | 2.05624201 |
| 17 | MP0010234_abnormal_vibrissa_follicle | 2.01827984 |
| 18 | MP0002132_abnormal_respiratory_system | 2.01002399 |
| 19 | * MP0001177_atelectasis | 1.95589297 |
| 20 | MP0008875_abnormal_xenobiotic_pharmacok | 1.75729911 |
| 21 | MP0004272_abnormal_basement_membrane | 1.74959312 |
| 22 | MP0000566_synostosis | 1.73911948 |
| 23 | MP0010352_gastrointestinal_tract_polyps | 1.51950883 |
| 24 | MP0002277_abnormal_respiratory_mucosa | 1.50760456 |
| 25 | MP0005058_abnormal_lysosome_morphology | 1.50007263 |
| 26 | MP0005503_abnormal_tendon_morphology | 1.44876323 |
| 27 | MP0003950_abnormal_plasma_membrane | 1.41023584 |
| 28 | MP0003566_abnormal_cell_adhesion | 1.34357397 |
| 29 | MP0003115_abnormal_respiratory_system | 1.32558218 |
| 30 | MP0003690_abnormal_glial_cell | 1.32040592 |
| 31 | MP0009780_abnormal_chondrocyte_physiolo | 1.30257569 |
| 32 | MP0001440_abnormal_grooming_behavior | 1.29789683 |
| 33 | * MP0001175_abnormal_lung_morphology | 1.29508675 |
| 34 | MP0002998_abnormal_bone_remodeling | 1.26566821 |
| 35 | MP0000534_abnormal_ureter_morphology | 1.25232769 |
| 36 | MP0005275_abnormal_skin_tensile | 1.25072436 |
| 37 | MP0004883_abnormal_blood_vessel | 1.17190616 |
| 38 | MP0003786_premature_aging | 1.13932254 |
| 39 | MP0005165_increased_susceptibility_to | 1.12069396 |
| 40 | MP0005164_abnormal_response_to | 1.10933346 |
| 41 | MP0000343_altered_response_to | 1.07492350 |
| 42 | MP0000767_abnormal_smooth_muscle | 1.06227944 |
| 43 | MP0000249_abnormal_blood_vessel | 1.03429242 |
| 44 | MP0009840_abnormal_foam_cell | 1.01404800 |
| 45 | MP0002139_abnormal_hepatobiliary_system | 1.00069304 |
| 46 | MP0001851_eye_inflammation | 0.99451902 |
| 47 | MP0005023_abnormal_wound_healing | 0.98212317 |
| 48 | MP0002098_abnormal_vibrissa_morphology | 0.96157417 |
| 49 | MP0006054_spinal_hemorrhage | 0.95254028 |
| 50 | MP0003303_peritoneal_inflammation | 0.92700172 |
| 51 | MP0005085_abnormal_gallbladder_physiolo | 0.91978673 |
| 52 | MP0005166_decreased_susceptibility_to | 0.91806399 |
| 53 | MP0010678_abnormal_skin_adnexa | 0.90281872 |
| 54 | MP0002234_abnormal_pharynx_morphology | 0.89118069 |
| 55 | MP0001545_abnormal_hematopoietic_system | 0.88661866 |
| 56 | MP0005397_hematopoietic_system_phenotyp | 0.88661866 |
| 57 | MP0003091_abnormal_cell_migration | 0.88475912 |
| 58 | MP0006138_congestive_heart_failure | 0.88128807 |
| 59 | MP0005595_abnormal_vascular_smooth | 0.88106389 |
| 60 | MP0002796_impaired_skin_barrier | 0.87755369 |
| 61 | MP0004185_abnormal_adipocyte_glucose | 0.86255731 |
| 62 | MP0002909_abnormal_adrenal_gland | 0.82564050 |
| 63 | MP0000013_abnormal_adipose_tissue | 0.82464176 |
| 64 | MP0004484_altered_response_of | 0.82428338 |
| 65 | MP0005408_hypopigmentation | 0.81527333 |
| 66 | MP0001664_abnormal_digestion | 0.81207953 |
| 67 | MP0001756_abnormal_urination | 0.79366843 |
| 68 | MP0000465_gastrointestinal_hemorrhage | 0.78231481 |
| 69 | MP0002332_abnormal_exercise_endurance | 0.77941407 |
| 70 | MP0004947_skin_inflammation | 0.77536549 |
| 71 | MP0002877_abnormal_melanocyte_morpholog | 0.75977384 |
| 72 | MP0003705_abnormal_hypodermis_morpholog | 0.75742013 |
| 73 | MP0000462_abnormal_digestive_system | 0.75631678 |
| 74 | MP0003075_altered_response_to | 0.74954103 |
| 75 | MP0002405_respiratory_system_inflammati | 0.74763295 |
| 76 | MP0003279_aneurysm | 0.74543786 |
| 77 | * MP0001943_abnormal_respiration | 0.74137075 |
| 78 | MP0000516_abnormal_urinary_system | 0.73207012 |
| 79 | MP0005367_renal/urinary_system_phenotyp | 0.73207012 |
| 80 | MP0005025_abnormal_response_to | 0.73047135 |
| 81 | MP0002419_abnormal_innate_immunity | 0.72828442 |
| 82 | MP0001666_abnormal_nutrient_absorption | 0.71195135 |
| 83 | MP0010329_abnormal_lipoprotein_level | 0.70547587 |
| 84 | MP0001533_abnormal_skeleton_physiology | 0.70057731 |
| 85 | MP0008438_abnormal_cutaneous_collagen | 0.69996130 |
| 86 | MP0002166_altered_tumor_susceptibility | 0.69148467 |
| 87 | * MP0002118_abnormal_lipid_homeostasis | 0.68526592 |
| 88 | MP0002128_abnormal_blood_circulation | 0.68031035 |
| 89 | MP0001501_abnormal_sleep_pattern | 0.67573658 |
| 90 | MP0006082_CNS_inflammation | 0.67055551 |
| 91 | MP0002925_abnormal_cardiovascular_devel | 0.66989496 |
| 92 | MP0003119_abnormal_digestive_system | 0.66474459 |
| 93 | MP0003448_altered_tumor_morphology | 0.65878595 |
| 94 | MP0003890_abnormal_embryonic-extraembry | 0.64993996 |
| 95 | MP0000681_abnormal_thyroid_gland | 0.63147150 |
| 96 | MP0004085_abnormal_heartbeat | 0.63055804 |
| 97 | MP0002168_other_aberrant_phenotype | 0.62924382 |
| 98 | MP0003656_abnormal_erythrocyte_physiolo | 0.62796736 |
| 99 | MP0003453_abnormal_keratinocyte_physiol | 0.62039944 |
| 100 | MP0000627_abnormal_mammary_gland | 0.60640460 |
| 101 | MP0001986_abnormal_taste_sensitivity | 0.60261736 |
| 102 | MP0001614_abnormal_blood_vessel | 0.59624136 |
| 103 | MP0001661_extended_life_span | 0.59386490 |
| 104 | MP0002933_joint_inflammation | 0.59249037 |
| 105 | MP0001849_ear_inflammation | 0.58718662 |
| 106 | MP0001853_heart_inflammation | 0.58683155 |
| 107 | MP0004084_abnormal_cardiac_muscle | 0.58405922 |
| 108 | MP0009643_abnormal_urine_homeostasis | 0.58095027 |
| 109 | MP0008961_abnormal_basal_metabolism | 0.57737564 |
| 110 | MP0002136_abnormal_kidney_physiology | 0.57319083 |
| 111 | MP0004858_abnormal_nervous_system | 0.56990526 |
| 112 | MP0003329_amyloid_beta_deposits | 0.56399999 |
| 113 | MP0003300_gastrointestinal_ulcer | 0.56157073 |
| 114 | MP0003638_abnormal_response/metabolism_ | 0.55721569 |
| 115 | MP0003436_decreased_susceptibility_to | 0.55623698 |
| 116 | MP0004130_abnormal_muscle_cell | 0.54810681 |
| 117 | MP0000383_abnormal_hair_follicle | 0.54428150 |
| 118 | MP0008775_abnormal_heart_ventricle | 0.53121852 |
| 119 | MP0000685_abnormal_immune_system | 0.52952053 |
| 120 | MP0003045_fibrosis | 0.52749899 |
| 121 | MP0009764_decreased_sensitivity_to | 0.51871831 |
| 122 | MP0000639_abnormal_adrenal_gland | 0.51245222 |
| 123 | MP0005647_abnormal_sex_gland | 0.50105802 |
| 124 | MP0005257_abnormal_intraocular_pressure | 0.49901805 |
| 125 | MP0002135_abnormal_kidney_morphology | 0.49406017 |
| 126 | MP0009384_cardiac_valve_regurgitation | 0.49174769 |
| 127 | MP0003828_pulmonary_edema | 0.48774352 |
| 128 | MP0001790_abnormal_immune_system | 0.48468909 |
| 129 | MP0005387_immune_system_phenotype | 0.48468909 |
| 130 | MP0002733_abnormal_thermal_nociception | 0.46933111 |
| 131 | MP0005390_skeleton_phenotype | 0.45013773 |
| 132 | MP0003795_abnormal_bone_structure | 0.44980937 |
| 133 | MP0009785_altered_susceptibility_to | 0.43040575 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hyperactive renin-angiotensin system (HP:0000841) | 7.79413579 |
| 2 | Tubulointerstitial fibrosis (HP:0005576) | 6.82793807 |
| 3 | Chronic bronchitis (HP:0004469) | 6.50676855 |
| 4 | Renal salt wasting (HP:0000127) | 6.24654313 |
| 5 | Abnormality of the fingertips (HP:0001211) | 5.90266041 |
| 6 | Systemic lupus erythematosus (HP:0002725) | 5.40943706 |
| 7 | Gout (HP:0001997) | 5.33729441 |
| 8 | Polycythemia (HP:0001901) | 5.27876882 |
| 9 | Complement deficiency (HP:0004431) | 5.13170638 |
| 10 | Glomerulonephritis (HP:0000099) | 5.01907646 |
| 11 | Neurofibrillary tangles (HP:0002185) | 4.84701345 |
| 12 | Hyperkalemia (HP:0002153) | 4.75189760 |
| 13 | Alveolar cell carcinoma (HP:0006519) | 4.73955008 |
| 14 | Onycholysis (HP:0001806) | 4.48229666 |
| 15 | Abnormality of complement system (HP:0005339) | 4.40695462 |
| 16 | Neoplasm of the tracheobronchial system (HP:0100552) | 4.38777489 |
| 17 | * Respiratory distress (HP:0002098) | 4.29335943 |
| 18 | Hematochezia (HP:0002573) | 4.24820604 |
| 19 | * Tachypnea (HP:0002789) | 4.00162448 |
| 20 | Cerebral inclusion bodies (HP:0100314) | 3.92217131 |
| 21 | Tubulointerstitial abnormality (HP:0001969) | 3.86286564 |
| 22 | Abnormality of the nasal mucosa (HP:0000433) | 3.79965321 |
| 23 | Thyroid-stimulating hormone excess (HP:0002925) | 3.75451978 |
| 24 | Hyperaldosteronism (HP:0000859) | 3.73125955 |
| 25 | Ulnar bowing (HP:0003031) | 3.70195721 |
| 26 | Nephritis (HP:0000123) | 3.60582013 |
| 27 | Tubulointerstitial nephritis (HP:0001970) | 3.57089353 |
| 28 | Spontaneous hematomas (HP:0007420) | 3.52555130 |
| 29 | Exertional dyspnea (HP:0002875) | 3.51924732 |
| 30 | Visceral angiomatosis (HP:0100761) | 3.51163742 |
| 31 | Abnormality of chloride homeostasis (HP:0011422) | 3.45469686 |
| 32 | Hypotension (HP:0002615) | 3.34176818 |
| 33 | Hemangiomatosis (HP:0007461) | 3.29701617 |
| 34 | Long toe (HP:0010511) | 3.25167777 |
| 35 | Abnormality of renin-angiotensin system (HP:0000847) | 3.22884210 |
| 36 | Aortic aneurysm (HP:0004942) | 3.20941601 |
| 37 | Neonatal respiratory distress (HP:0002643) | 3.16554550 |
| 38 | Broad metatarsal (HP:0001783) | 3.15683106 |
| 39 | Bronchitis (HP:0012387) | 3.11578352 |
| 40 | Supranuclear gaze palsy (HP:0000605) | 3.09617919 |
| 41 | Pulmonary fibrosis (HP:0002206) | 3.04300973 |
| 42 | Esophageal varix (HP:0002040) | 3.03430595 |
| 43 | Eczematoid dermatitis (HP:0000976) | 2.93306749 |
| 44 | * Pulmonary hypertension (HP:0002092) | 2.91358148 |
| 45 | Tubular atrophy (HP:0000092) | 2.91255256 |
| 46 | Loss of speech (HP:0002371) | 2.89766213 |
| 47 | Hypergammaglobulinemia (HP:0010702) | 2.88625676 |
| 48 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.77943966 |
| 49 | Chronic otitis media (HP:0000389) | 2.77454671 |
| 50 | Hyponatremia (HP:0002902) | 2.66731792 |
| 51 | Bowing of the arm (HP:0006488) | 2.66645102 |
| 52 | Bowed forearm bones (HP:0003956) | 2.66645102 |
| 53 | Fragile nails (HP:0001808) | 2.65516410 |
| 54 | Decreased circulating renin level (HP:0003351) | 2.65133649 |
| 55 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.63781066 |
| 56 | Cerebral aneurysm (HP:0004944) | 2.62169899 |
| 57 | Neoplasm of the lung (HP:0100526) | 2.61064320 |
| 58 | Growth hormone excess (HP:0000845) | 2.60439260 |
| 59 | Abnormality of the fetal cardiovascular system (HP:0010948) | 2.59650064 |
| 60 | Abnormal umbilical cord blood vessels (HP:0011403) | 2.59650064 |
| 61 | Single umbilical artery (HP:0001195) | 2.59650064 |
| 62 | Striae distensae (HP:0001065) | 2.48796240 |
| 63 | Bronchomalacia (HP:0002780) | 2.47947905 |
| 64 | Glomerulosclerosis (HP:0000096) | 2.46795750 |
| 65 | Osteolytic defects of the hand bones (HP:0009699) | 2.38042742 |
| 66 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.38042742 |
| 67 | Atrophic scars (HP:0001075) | 2.37795259 |
| 68 | Milia (HP:0001056) | 2.33901425 |
| 69 | Conjunctival telangiectasia (HP:0000524) | 2.32950311 |
| 70 | Restrictive lung disease (HP:0002091) | 2.30956918 |
| 71 | Increased purine levels (HP:0004368) | 2.27820947 |
| 72 | Hyperuricemia (HP:0002149) | 2.27820947 |
| 73 | Neoplasm of the respiratory system (HP:0100606) | 2.24366318 |
| 74 | Potter facies (HP:0002009) | 2.23008787 |
| 75 | Facial shape deformation (HP:0011334) | 2.23008787 |
| 76 | Cerebral hemorrhage (HP:0001342) | 2.21988243 |
| 77 | Adrenal overactivity (HP:0002717) | 2.20258312 |
| 78 | Aortic dissection (HP:0002647) | 2.17845714 |
| 79 | Stomach cancer (HP:0012126) | 2.15977307 |
| 80 | Ulnar claw (HP:0001178) | 2.15973283 |
| 81 | Glucose intolerance (HP:0000833) | 2.14248719 |
| 82 | Subacute progressive viral hepatitis (HP:0006572) | 2.13277081 |
| 83 | Megalencephaly (HP:0001355) | 2.12456365 |
| 84 | Abnormality of sodium homeostasis (HP:0010931) | 2.11728056 |
| 85 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.11260372 |
| 86 | Deep venous thrombosis (HP:0002625) | 2.08120410 |
| 87 | Abnormality of macrophages (HP:0004311) | 2.03947429 |
| 88 | Increased CSF protein (HP:0002922) | 2.02582942 |
| 89 | Shallow orbits (HP:0000586) | 2.01642703 |
| 90 | Stenosis of the external auditory canal (HP:0000402) | 2.00424527 |
| 91 | * Interstitial pulmonary disease (HP:0006530) | 10.1912716 |
| 92 | Hypokalemic alkalosis (HP:0001949) | 1.99456822 |
| 93 | Pulmonary artery stenosis (HP:0004415) | 1.90507309 |
| 94 | Mitral valve prolapse (HP:0001634) | 1.89363506 |
| 95 | Abnormality of the gastric mucosa (HP:0004295) | 1.88525540 |
| 96 | Skin nodule (HP:0200036) | 1.86957819 |
| 97 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.86935509 |
| 98 | Humeroradial synostosis (HP:0003041) | 1.86918131 |
| 99 | Synostosis involving the elbow (HP:0003938) | 1.86918131 |
| 100 | Microcytic anemia (HP:0001935) | 1.86316403 |
| 101 | Joint swelling (HP:0001386) | 1.85950199 |
| 102 | Hyperpituitarism (HP:0010514) | 1.84054399 |
| 103 | Flexion contracture of toe (HP:0005830) | 1.82928274 |
| 104 | Joint contractures involving the joints of the feet (HP:0100492) | 1.82928274 |
| 105 | Abnormality of purine metabolism (HP:0004352) | 1.82309224 |
| 106 | Prostate neoplasm (HP:0100787) | 1.82263738 |
| 107 | Bronchiectasis (HP:0002110) | 1.81435950 |
| 108 | Turricephaly (HP:0000262) | 1.79713905 |
| 109 | Aneurysm (HP:0002617) | 1.79585516 |
| 110 | Aplasia involving bones of the extremities (HP:0009825) | 1.77153231 |
| 111 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.77153231 |
| 112 | Aplasia of the phalanges of the hand (HP:0009802) | 1.77153231 |
| 113 | Cavernous hemangioma (HP:0001048) | 1.74388768 |
| 114 | Rectal prolapse (HP:0002035) | 1.71912683 |
| 115 | Wormian bones (HP:0002645) | 1.71325219 |
| 116 | Prolonged neonatal jaundice (HP:0006579) | 1.70837239 |
| 117 | Progressive sensorineural hearing impairment (HP:0000408) | 1.70796007 |
| 118 | Right ventricular cardiomyopathy (HP:0011663) | 1.70256382 |
| 119 | Shawl scrotum (HP:0000049) | 1.70170583 |
| 120 | Annular pancreas (HP:0001734) | 1.68253735 |
| 121 | Camptodactyly of toe (HP:0001836) | 1.67405758 |
| 122 | Thickened helices (HP:0000391) | 1.66668847 |
| 123 | Dilatation of the ascending aorta (HP:0005111) | 1.66150404 |
| 124 | Buphthalmos (HP:0000557) | 1.65832027 |
| 125 | Adactyly (HP:0009776) | 1.64272096 |
| 126 | Distal lower limb muscle weakness (HP:0009053) | 1.64008404 |
| 127 | Plantar hyperkeratosis (HP:0007556) | 1.63942546 |
| 128 | Vascular tortuosity (HP:0004948) | 1.63928947 |
| 129 | Mitral stenosis (HP:0001718) | 1.63568333 |
| 130 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.62842816 |
| 131 | Mucopolysacchariduria (HP:0008155) | 1.62842816 |
| 132 | Recurrent abscess formation (HP:0002722) | 1.62595458 |
| 133 | Dehydration (HP:0001944) | 1.62560876 |
| 134 | Aortic valve stenosis (HP:0001650) | 1.62228231 |
| 135 | Arterial tortuosity (HP:0005116) | 1.61786472 |
| 136 | Seborrheic dermatitis (HP:0001051) | 1.58974666 |
| 137 | Increased connective tissue (HP:0009025) | 1.58803314 |
| 138 | Split foot (HP:0001839) | 1.58613920 |
| 139 | Pustule (HP:0200039) | 1.58525627 |
| 140 | Abnormal hemoglobin (HP:0011902) | 1.57897126 |
| 141 | Cerebral palsy (HP:0100021) | 1.57170374 |
| 142 | Abnormality of the renal collecting system (HP:0004742) | 1.56339247 |
| 143 | Absent hand (HP:0004050) | 1.54975670 |
| 144 | Abnormal glucose tolerance (HP:0001952) | 1.52806162 |
| 145 | Portal hypertension (HP:0001409) | 1.50947959 |
| 146 | Joint hemorrhage (HP:0005261) | 1.49029276 |
| 147 | Persistence of primary teeth (HP:0006335) | 1.48980553 |
| 148 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.47806705 |
| 149 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.47563847 |
| 150 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.47563847 |
| 151 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.47563847 |
| 152 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.47144409 |
| 153 | Overgrowth (HP:0001548) | 1.46564306 |
| 154 | Abnormality of the periventricular white matter (HP:0002518) | 1.46338040 |
| 155 | Gingivitis (HP:0000230) | 1.46042362 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TIE1 | 5.04811236 |
| 2 | STK24 | 4.42444197 |
| 3 | FGFR2 | 4.31682857 |
| 4 | LRRK2 | 3.54259084 |
| 5 | TGFBR2 | 3.50543390 |
| 6 | ZAP70 | 2.81326264 |
| 7 | TRIB3 | 2.66778186 |
| 8 | EPHB1 | 2.61907495 |
| 9 | PAK4 | 2.38630068 |
| 10 | RIPK1 | 2.36287078 |
| 11 | DAPK2 | 2.26264080 |
| 12 | EPHB2 | 2.22145945 |
| 13 | EPHA2 | 2.13257143 |
| 14 | MST4 | 2.08861433 |
| 15 | NLK | 2.05603612 |
| 16 | ILK | 2.00029358 |
| 17 | PDGFRB | 1.98307352 |
| 18 | ERN1 | 1.93600985 |
| 19 | CDC42BPA | 1.92377653 |
| 20 | FER | 1.81780973 |
| 21 | MAP3K2 | 1.77983475 |
| 22 | STK10 | 1.74191366 |
| 23 | FGFR4 | 1.73793665 |
| 24 | STK38L | 1.68518490 |
| 25 | MAPK15 | 1.54010637 |
| 26 | IRAK1 | 1.50056212 |
| 27 | PTK6 | 1.49075406 |
| 28 | LATS2 | 1.45951921 |
| 29 | MAP3K6 | 1.41745621 |
| 30 | PRPF4B | 1.40892023 |
| 31 | MST1R | 1.38629408 |
| 32 | GRK1 | 1.38447778 |
| 33 | TYK2 | 1.38000958 |
| 34 | MAP3K9 | 1.36683215 |
| 35 | KSR2 | 1.34255176 |
| 36 | MAP3K14 | 1.33016384 |
| 37 | LMTK2 | 1.32215023 |
| 38 | PDGFRA | 1.31647384 |
| 39 | MYLK | 1.28158066 |
| 40 | MAP3K13 | 1.25181208 |
| 41 | TAOK3 | 1.21197418 |
| 42 | CAMK1D | 1.19941401 |
| 43 | CDK6 | 1.19641864 |
| 44 | EPHA3 | 1.16502756 |
| 45 | MET | 1.15793723 |
| 46 | AKT3 | 1.14954815 |
| 47 | YES1 | 1.14525348 |
| 48 | TRPM7 | 1.12738647 |
| 49 | TESK1 | 1.09748392 |
| 50 | FGFR3 | 1.09083385 |
| 51 | LATS1 | 1.07061903 |
| 52 | GSK3A | 1.05980057 |
| 53 | KIT | 1.05011554 |
| 54 | MAP3K3 | 1.04078516 |
| 55 | MAPK7 | 1.01468521 |
| 56 | TGFBR1 | 0.94596968 |
| 57 | EGFR | 0.92978415 |
| 58 | SIK1 | 0.91665993 |
| 59 | PTK2 | 0.91562843 |
| 60 | CSK | 0.88589502 |
| 61 | PRKD1 | 0.88137775 |
| 62 | SGK2 | 0.83907555 |
| 63 | CAMK1G | 0.82999359 |
| 64 | BLK | 0.80887898 |
| 65 | KDR | 0.80618618 |
| 66 | BCR | 0.80051109 |
| 67 | MAPK12 | 0.79689801 |
| 68 | NTRK1 | 0.78722128 |
| 69 | MAP2K3 | 0.75637855 |
| 70 | MAP2K2 | 0.73509666 |
| 71 | MAP3K1 | 0.72593335 |
| 72 | MAP3K12 | 0.72186158 |
| 73 | PKN2 | 0.67080386 |
| 74 | LIMK1 | 0.66818676 |
| 75 | ERBB2 | 0.65832440 |
| 76 | DDR2 | 0.63827383 |
| 77 | PDK2 | 0.63686964 |
| 78 | NEK9 | 0.62098499 |
| 79 | MARK2 | 0.61885811 |
| 80 | SGK223 | 0.61601646 |
| 81 | SGK494 | 0.61601646 |
| 82 | DAPK3 | 0.61122241 |
| 83 | DMPK | 0.60694181 |
| 84 | PDPK1 | 0.60357527 |
| 85 | STK38 | 0.60120983 |
| 86 | ERBB4 | 0.59995940 |
| 87 | FGFR1 | 0.57188458 |
| 88 | PTK2B | 0.57013163 |
| 89 | MAP2K1 | 0.55511732 |
| 90 | PRKCQ | 0.53921087 |
| 91 | DAPK1 | 0.53299114 |
| 92 | RPS6KA4 | 0.52700342 |
| 93 | INSR | 0.51473011 |
| 94 | MELK | 0.50899390 |
| 95 | NEK6 | 0.50806980 |
| 96 | RET | 0.48892620 |
| 97 | TYRO3 | 0.47744532 |
| 98 | MAPKAPK2 | 0.47535235 |
| 99 | STK39 | 0.47245043 |
| 100 | MAP3K7 | 0.47009334 |
| 101 | MATK | 0.46909753 |
| 102 | ROCK2 | 0.46216772 |
| 103 | RPS6KC1 | 0.46162153 |
| 104 | RPS6KL1 | 0.46162153 |
| 105 | GRK5 | 0.46131049 |
| 106 | NME1 | 0.46128980 |
| 107 | ERBB3 | 0.43010929 |
| 108 | PRKCH | 0.41674307 |
| 109 | BMX | 0.39771127 |
| 110 | TTN | 0.39401414 |
| 111 | PRKG2 | 0.38898739 |
| 112 | MAPK3 | 0.38379061 |
| 113 | MTOR | 0.37263061 |
| 114 | STK3 | 0.37059656 |
| 115 | GRK7 | 0.36214183 |
| 116 | ABL1 | 0.35931592 |
| 117 | RPS6KA6 | 0.35874335 |
| 118 | HIPK2 | 0.35709797 |
| 119 | DYRK1B | 0.35346501 |
| 120 | PRKCE | 0.34634420 |
| 121 | JAK1 | 0.33078433 |
| 122 | MAPK4 | 0.31961099 |
| 123 | FYN | 0.31848090 |
| 124 | MAPK1 | 0.31034886 |
| 125 | WNK4 | 0.30513721 |
| 126 | RPS6KA5 | 0.30496601 |
| 127 | RPS6KA2 | 0.29070207 |
| 128 | FGR | 0.28512236 |
| 129 | CHUK | 0.27045388 |
| 130 | FES | 0.26956709 |
| 131 | ROCK1 | 0.26855814 |
| 132 | TEC | 0.26596053 |
| 133 | IGF1R | 0.26377047 |
| 134 | SGK3 | 0.25314243 |
| 135 | MAP2K6 | 0.25235264 |
| 136 | SRC | 0.24522674 |
| 137 | ICK | 0.23570799 |
| 138 | JAK2 | 0.23193410 |
| 139 | TBK1 | 0.22471605 |
| 140 | PRKD2 | 0.22272420 |
| 141 | MAP3K8 | 0.21859357 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 3.47831441 |
| 2 | Mineral absorption_Homo sapiens_hsa04978 | 3.25874938 |
| 3 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.51370243 |
| 4 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.35014126 |
| 5 | Adherens junction_Homo sapiens_hsa04520 | 2.31503699 |
| 6 | Lysosome_Homo sapiens_hsa04142 | 2.19072176 |
| 7 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.09171828 |
| 8 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 2.04343372 |
| 9 | Asthma_Homo sapiens_hsa05310 | 2.03960678 |
| 10 | Tight junction_Homo sapiens_hsa04530 | 1.92446771 |
| 11 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.80849575 |
| 12 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.77516061 |
| 13 | Bladder cancer_Homo sapiens_hsa05219 | 1.75365619 |
| 14 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.75342643 |
| 15 | Phagosome_Homo sapiens_hsa04145 | 1.73051647 |
| 16 | Allograft rejection_Homo sapiens_hsa05330 | 1.71888919 |
| 17 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.68050361 |
| 18 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.66839866 |
| 19 | Focal adhesion_Homo sapiens_hsa04510 | 1.65617082 |
| 20 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.48890309 |
| 21 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.44282594 |
| 22 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.43584522 |
| 23 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.41512105 |
| 24 | Pertussis_Homo sapiens_hsa05133 | 1.41363883 |
| 25 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.38026405 |
| 26 | Leishmaniasis_Homo sapiens_hsa05140 | 1.30844560 |
| 27 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.30258961 |
| 28 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.27519548 |
| 29 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.26677653 |
| 30 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.26150634 |
| 31 | Amoebiasis_Homo sapiens_hsa05146 | 1.25512803 |
| 32 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.24504074 |
| 33 | Malaria_Homo sapiens_hsa05144 | 1.19340796 |
| 34 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.18478208 |
| 35 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.15154427 |
| 36 | Thyroid cancer_Homo sapiens_hsa05216 | 1.15091937 |
| 37 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 1.13058066 |
| 38 | Circadian rhythm_Homo sapiens_hsa04710 | 1.12157085 |
| 39 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.11677045 |
| 40 | Platelet activation_Homo sapiens_hsa04611 | 1.10219973 |
| 41 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.09713610 |
| 42 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.09528962 |
| 43 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.07143543 |
| 44 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.07094690 |
| 45 | Histidine metabolism_Homo sapiens_hsa00340 | 1.06805325 |
| 46 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.05758690 |
| 47 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.04310951 |
| 48 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.04115690 |
| 49 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.03104739 |
| 50 | Endocytosis_Homo sapiens_hsa04144 | 1.01551287 |
| 51 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.00131408 |
| 52 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.00078135 |
| 53 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.99819241 |
| 54 | Taste transduction_Homo sapiens_hsa04742 | 0.98944761 |
| 55 | Renin secretion_Homo sapiens_hsa04924 | 0.97323241 |
| 56 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.96752732 |
| 57 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.96323643 |
| 58 | Endometrial cancer_Homo sapiens_hsa05213 | 0.95945340 |
| 59 | Axon guidance_Homo sapiens_hsa04360 | 0.95195899 |
| 60 | Other glycan degradation_Homo sapiens_hsa00511 | 0.94041519 |
| 61 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.93611456 |
| 62 | ABC transporters_Homo sapiens_hsa02010 | 0.92472825 |
| 63 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.90222151 |
| 64 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.88822436 |
| 65 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.88711163 |
| 66 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.88650436 |
| 67 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.85707725 |
| 68 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.84067293 |
| 69 | Salmonella infection_Homo sapiens_hsa05132 | 0.82885783 |
| 70 | Salivary secretion_Homo sapiens_hsa04970 | 0.80976763 |
| 71 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.80410998 |
| 72 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.77870691 |
| 73 | Viral myocarditis_Homo sapiens_hsa05416 | 0.77703412 |
| 74 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.76840857 |
| 75 | Influenza A_Homo sapiens_hsa05164 | 0.75661159 |
| 76 | Bile secretion_Homo sapiens_hsa04976 | 0.75023336 |
| 77 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.74333374 |
| 78 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.74249958 |
| 79 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.74024425 |
| 80 | Pathways in cancer_Homo sapiens_hsa05200 | 0.73477371 |
| 81 | Prion diseases_Homo sapiens_hsa05020 | 0.73430387 |
| 82 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.71653570 |
| 83 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.71420471 |
| 84 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.71170484 |
| 85 | Hepatitis C_Homo sapiens_hsa05160 | 0.71078259 |
| 86 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.69962097 |
| 87 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.69060053 |
| 88 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.68979091 |
| 89 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.67154569 |
| 90 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.67134183 |
| 91 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.66390677 |
| 92 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.66094310 |
| 93 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.65975292 |
| 94 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.64507132 |
| 95 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.63395964 |
| 96 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.63271865 |
| 97 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.62905981 |
| 98 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.60192072 |
| 99 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.59826932 |
| 100 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.59430787 |
| 101 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.58147465 |
| 102 | Shigellosis_Homo sapiens_hsa05131 | 0.57876299 |
| 103 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.56629511 |
| 104 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.56029134 |
| 105 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.55635754 |
| 106 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.54998155 |
| 107 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.54721634 |
| 108 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.53645093 |
| 109 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.50553333 |
| 110 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.50138989 |
| 111 | Colorectal cancer_Homo sapiens_hsa05210 | 0.49889337 |
| 112 | Melanoma_Homo sapiens_hsa05218 | 0.48340968 |
| 113 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.47492425 |
| 114 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.47330758 |
| 115 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.46875191 |
| 116 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.46712019 |
| 117 | Apoptosis_Homo sapiens_hsa04210 | 0.45991130 |
| 118 | Insulin resistance_Homo sapiens_hsa04931 | 0.45489654 |
| 119 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.45105694 |
| 120 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.45020347 |
| 121 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.44978048 |
| 122 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.44642298 |
| 123 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.44372185 |
| 124 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.43162983 |
| 125 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.42983119 |
| 126 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.42507373 |
| 127 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.42243480 |
| 128 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.42048023 |
| 129 | Prostate cancer_Homo sapiens_hsa05215 | 0.41908057 |
| 130 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.40309498 |
| 131 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.40068164 |
| 132 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.39907735 |
| 133 | Gap junction_Homo sapiens_hsa04540 | 0.39782995 |
| 134 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.39695210 |
| 135 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.38883025 |
| 136 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.38882546 |
| 137 | Tuberculosis_Homo sapiens_hsa05152 | 0.38137287 |
| 138 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.37974367 |

